Insider Trading & Ownership - Vivo Capital VIII LLC

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Vivo Capital VIII LLC
Common stock purchase or sale:
Transaction
Date		Reported
DateTime		CompanySymbolInsider
Relationship		Shares
Traded		Average
Price		Total
Amount		Shares
Owned		Filing
2024-04-01
Sale		2024-04-03
8:47 pm		Terns Pharmaceuticals Inc.TERNVivo Opportunity LLC
Vivo Opportunity Fund Holdings L.P.
Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner		420,663$6.6487$2,796,859268,573
(Indirect)		View
2023-12-15
Sale		2023-12-19
6:00 pm		IMPEL PHARMACEUTICALS INCIMPLVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner		575,000$0.12892$74,131280,294
(Indirect)		View
2023-11-21
Sale		2023-11-22
6:51 pm		Bolt Biotherapeutics Inc.BOLTVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Opportunity LLC
Vivo Opportunity Fund Holdings L.P.
Vivo Panda LLC
Vivo Panda Fund L.P.
10% Owner		3,400$0.9$3,0601,559,948
(Indirect)		View
2023-11-16
Sale		2023-11-20
9:09 pm		Bolt Biotherapeutics Inc.BOLTVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Opportunity LLC
Vivo Opportunity Fund Holdings L.P.
Vivo Panda LLC
Vivo Panda Fund L.P.
10% Owner		77,843$0.92875$72,2971,561,405
(Indirect)		View
2022-12-23
Purchase		2022-12-23
5:48 pm		Terns Pharmaceuticals Inc.TERNVivo Opportunity LLC
Vivo Opportunity Fund Holdings L.P.
Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner		758,620$7.25$5,499,9956,657,992
(Indirect)		View
2022-09-07
Purchase		2022-09-08
8:00 pm		Terns Pharmaceuticals Inc.TERNVivo Opportunity LLC
Vivo Opportunity Fund Holdings L.P.
Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner		600,000$3.6$2,160,0005,899,372
(Indirect)		View
2022-08-12
Purchase		2022-08-16
8:44 pm		Terns Pharmaceuticals Inc.TERNVivo Opportunity LLC
Vivo Opportunity Fund Holdings L.P.
Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner		2,624,239$2.6599$6,980,2446,799,372
(Indirect)		View
2021-04-27
Purchase		2021-04-29
9:10 pm		IMPEL NEUROPHARMA INCIMPLVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner		575,000$15$8,625,000349,674
(Indirect)		View
2021-02-09
Purchase		2021-02-09
3:37 pm		Bolt Biotherapeutics Inc.BOLTVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Panda Fund L.P.
Vivo Panda LLC
Vivo Opportunity Fund L.P.
Vivo Opportunity LLC
10% Owner		350,000$20$7,000,000150,000
(Indirect)		View
2021-02-09
Sale		2021-02-09
3:37 pm		Bolt Biotherapeutics Inc.BOLTVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Panda Fund L.P.
Vivo Panda LLC
Vivo Opportunity Fund L.P.
Vivo Opportunity LLC
10% Owner		226$20$4,520150,000
(Indirect)		View
2021-02-09
Purchase		2021-02-09
3:08 pm		Terns Pharmaceuticals Inc.TERNVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Opportunity LLC
Vivo Opportunity Fund L.P.
10% Owner		475,000$17$8,075,000357,353
(Indirect)		View
2020-10-20
Purchase		2020-10-20
4:59 pm		Aligos Therapeutics Inc.ALGSVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner		550,000$15$8,250,000430,372
(Indirect)		View
2020-04-15
Sale		2020-04-17
6:38 pm		Crinetics Pharmaceuticals Inc.CRNXVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner		330,598$15.45$5,106,752298,625
(Indirect)		View
2020-04-03
Sale		2020-04-07
7:27 pm		Crinetics Pharmaceuticals Inc.CRNXVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner		306,115$13.81$4,226,833338,738
(Indirect)		View
2020-03-09
Sale		2020-03-11
5:12 pm		Crinetics Pharmaceuticals Inc.CRNXVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Opportunity LLC
Vivo Opportunity Fund L.P.
10% Owner		528$19.5$10,296168,165
(Indirect)		View
2020-02-07
Sale		2020-02-11
8:00 pm		Crinetics Pharmaceuticals Inc.CRNXVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Opportunity LLC
Vivo Opportunity Fund L.P.
10% Owner		13,460$21.66$291,587168,298
(Indirect)		View
2020-02-04
Sale		2020-02-06
7:22 pm		Crinetics Pharmaceuticals Inc.CRNXVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Opportunity LLC
Vivo Opportunity Fund L.P.
10% Owner		13,460$22.8$306,888178,816
(Indirect)		View
2020-01-29
Sale		2020-01-31
8:00 pm		Crinetics Pharmaceuticals Inc.CRNXVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Opportunity LLC
Vivo Opportunity Fund L.P.
10% Owner		26,920$22.07$594,164189,335
(Indirect)		View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing
2021-04-27
Conversion		2021-04-29
9:10 pm		N/A
N/A		IMPEL NEUROPHARMA INCIMPLVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner		101,456$13.5349,674
(Indirect)		View
2021-04-27
Conversion		2021-04-29
9:10 pm		N/A
N/A		IMPEL NEUROPHARMA INCIMPLVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner		39,725,922$0349,674
(Indirect)		View
2021-04-22
Other		2021-04-26
6:24 pm		N/A
2021-12-31		IMPEL NEUROPHARMA INCIMPLVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner		1,359,799$01,359,799
(Indirect)		View

Ownership		2021-04-22
9:30 pm		N/A
N/A		IMPEL NEUROPHARMA INCIMPLVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner		0$02,208,333
(Indirect)		View
2021-02-09
Exercise		2021-02-09
3:37 pm		N/A
2028-07-26		Bolt Biotherapeutics Inc.BOLTVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Panda Fund L.P.
Vivo Panda LLC
Vivo Opportunity Fund L.P.
Vivo Opportunity LLC
10% Owner		64,319$0150,000
(Indirect)		View
2021-02-09
Exercise		2021-02-09
3:37 pm		N/A
N/A		Bolt Biotherapeutics Inc.BOLTVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Panda Fund L.P.
Vivo Panda LLC
Vivo Opportunity Fund L.P.
Vivo Opportunity LLC
10% Owner		64,319$0.07150,000
(Indirect)		View
2021-02-09
Conversion		2021-02-09
3:37 pm		N/A
N/A		Bolt Biotherapeutics Inc.BOLTVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Panda Fund L.P.
Vivo Panda LLC
Vivo Opportunity Fund L.P.
Vivo Opportunity LLC
10% Owner		3,414,343$0150,000
(Indirect)		View
2021-02-09
Conversion		2021-02-09
3:08 pm		N/A
N/A		Terns Pharmaceuticals Inc.TERNVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Opportunity LLC
Vivo Opportunity Fund L.P.
10% Owner		3,426,240$0357,353
(Indirect)		View

Ownership		2021-02-04
7:33 pm		N/A
N/A		Bolt Biotherapeutics Inc.BOLTVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Panda Fund L.P.
Vivo Panda LLC
10% Owner		0$03,521,517
(Indirect)		View

Ownership		2021-02-04
5:05 pm		N/A
N/A		Terns Pharmaceuticals Inc.TERNVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner		0$02,200,133
(Indirect)		View
2020-10-20
Conversion		2020-10-20
4:59 pm		N/A
N/A		Aligos Therapeutics Inc.ALGSVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner		2,997,030$0430,372
(Indirect)		View

Ownership		2020-10-15
5:17 pm		N/A
N/A		Aligos Therapeutics Inc.ALGSVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner		0$02,997,030
(Indirect)		View